Jason Kelly, Ginkgo Bioworks CEO and co-founder, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 9:30 AM Pacific Time at the Westin St. Francis Hotel in San Francisco, room Elizabethan D.
| BOSTON, Jan. 2, 2019 /PRNewswire/ -- Ginkgo Bioworks, the organism company, today announced that Jason Kelly, Ginkgo Bioworks CEO and co-founder, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 9:30 AM Pacific Time at the Westin St. Francis Hotel in San Francisco, room Elizabethan D. Ginkgo recently announced the opening of Bioworks4, the first automated foundry for genetically engineering mammalian cells used in the discovery and manufacturing of therapeutics. In his presentation, Kelly will discuss Ginkgo’s foundry approach and the potential for synthetic biology to accelerate innovation in pharma. About Ginkgo Bioworks Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet – biology – to grow products instead of manufacturing them. The company’s technology platform is bringing biotechnology into consumer goods markets, enabling fragrance, cosmetic, nutrition, food, agriculture and pharmaceuticals to make better products. For more information, visit www.ginkgobioworks.com. Contacts Media: Investors:
SOURCE Ginkgo Bioworks |
View original content:
